Literature DB >> 26101895

Optimized Replicating Renilla Luciferase Reporter HIV-1 Utilizing Novel Internal Ribosome Entry Site Elements for Native Nef Expression and Function.

Michael O Alberti1, Jennifer J Jones1, Riccardo Miglietta1, Haitao Ding1, Rakesh K Bakshi1, Tara G Edmonds1, John C Kappes1,2,3,4, Christina Ochsenbauer1,3,4.   

Abstract

We previously developed replication-competent reporter HIV-1 (referred to herein as LucR.T2A reporter viruses), utilizing a "ribosome skipping" T2A peptide strategy to link Renilla luciferase (LucR) with Nef expression. The demonstrated utility for HIV-1 vaccine and transmission study applications included measurement of neutralizing antibody (NAb) activity in vaccine sera, improved cell-mediated virus inhibition assays, such as T cell-mediated virus inhibition and antibody-dependent cell-mediated cytotoxicity (ADCC) assays, and humanized mouse models. Herein, we extend our prior work and introduce reporter virus technology for applications that require fully functional Nef. We demonstrate that in CD4(+) T cells productively infected with LucR.T2A reporter viruses, T2A peptide-driven Nef expression and function, such as down-regulation of surface CD4 and MHC-I, were impaired. We overcame this limitation of LucR.T2A reporter viruses and achieved physiological Nef expression and function by engineering novel LucR reporter HIV-1 comprising 11 different internal ribosome entry site (IRES) elements chosen for size and relative activity. A range of Nef expression was observed in 293T cells transfected with the different LucR.IRES reporter virus constructs. Iteratively, we identified IRES reporter genomes that expressed Nef closest to physiological levels and produced virus with infectivity, titers, and replication kinetics similar to nonreporter viruses. Our results demonstrated that LucR reporter activity was stable over multiple replication cycles in peripheral blood mononuclear cells (PBMCs). Furthermore, we analyzed Nef functionality, i.e., down-modulation of MHC-I and CD4, following infection of T cell lines and PBMCs. Unlike LucR.T2A reporter virus, one of the redesigned LucR.IRES reporter viruses [containing the modified encephalomyocarditis virus (EMCV) 6ATR IRES element, "6ATRi"] demonstrated Nef expression and function similar to parental "nonreporter" virus. In a previously validated (nef-independent) T cell-based NAb neutralization assay, LucR.6ATRi reporter virus performed indistinguishably from LucR.T2A reporter virus. In summary, reporter viruses comprising the "6ATRi" element promise to augment HIV-1 vaccine and transmission research approaches requiring a sensitive reporter readout combined with wild-type Nef function.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26101895      PMCID: PMC4663642          DOI: 10.1089/aid.2015.0074

Source DB:  PubMed          Journal:  AIDS Res Hum Retroviruses        ISSN: 0889-2229            Impact factor:   2.205


  83 in total

1.  HLA-A2 down-regulation on primary human macrophages infected with an M-tropic EGFP-tagged HIV-1 reporter virus.

Authors:  Amanda Brown; Suzanne Gartner; Thomas Kawano; Nicole Benoit; Cecilia Cheng-Mayer
Journal:  J Leukoc Biol       Date:  2005-07-06       Impact factor: 4.962

2.  Randomized, double-blind, placebo-controlled efficacy trial of a bivalent recombinant glycoprotein 120 HIV-1 vaccine among injection drug users in Bangkok, Thailand.

Authors:  Punnee Pitisuttithum; Peter Gilbert; Marc Gurwith; William Heyward; Michael Martin; Fritz van Griensven; Dale Hu; Jordan W Tappero; Kachit Choopanya
Journal:  J Infect Dis       Date:  2006-11-03       Impact factor: 5.226

3.  Comparison of picornaviral IRES-driven internal initiation of translation in cultured cells of different origins.

Authors:  A M Borman; P Le Mercier; M Girard; K M Kean
Journal:  Nucleic Acids Res       Date:  1997-03-01       Impact factor: 16.971

4.  Intravirion generation of the C-terminal core domain of HIV-1 Nef by the HIV-1 protease is insufficient to enhance viral infectivity.

Authors:  M D Miller; M T Warmerdam; S S Ferrell; R Benitez; W C Greene
Journal:  Virology       Date:  1997-08-04       Impact factor: 3.616

5.  Selected drugs with reported secondary cell-differentiating capacity prime latent HIV-1 infection for reactivation.

Authors:  Takao Shishido; Frank Wolschendorf; Alexandra Duverger; Frederic Wagner; John Kappes; Jennifer Jones; Olaf Kutsch
Journal:  J Virol       Date:  2012-06-13       Impact factor: 5.103

6.  Antibody-dependent cellular cytotoxicity against primary HIV-infected CD4+ T cells is directly associated with the magnitude of surface IgG binding.

Authors:  Adjoa Smalls-Mantey; Nicole Doria-Rose; Rachel Klein; Andy Patamawenu; Stephen A Migueles; Sung-Youl Ko; Claire W Hallahan; Hing Wong; Bai Liu; Lijing You; Johannes Scheid; John C Kappes; Christina Ochsenbauer; Gary J Nabel; John R Mascola; Mark Connors
Journal:  J Virol       Date:  2012-06-06       Impact factor: 5.103

7.  Structural basis for diverse N-glycan recognition by HIV-1-neutralizing V1-V2-directed antibody PG16.

Authors:  Marie Pancera; Syed Shahzad-Ul-Hussan; Nicole A Doria-Rose; Jason S McLellan; Robert T Bailer; Kaifan Dai; Sandra Loesgen; Mark K Louder; Ryan P Staupe; Yongping Yang; Baoshan Zhang; Robert Parks; Joshua Eudailey; Krissey E Lloyd; Julie Blinn; S Munir Alam; Barton F Haynes; Mohammed N Amin; Lai-Xi Wang; Dennis R Burton; Wayne C Koff; Gary J Nabel; John R Mascola; Carole A Bewley; Peter D Kwong
Journal:  Nat Struct Mol Biol       Date:  2013-05-26       Impact factor: 15.369

8.  Prediction of lipid posttranslational modifications and localization signals from protein sequences: big-Pi, NMT and PTS1.

Authors:  Frank Eisenhaber; Birgit Eisenhaber; Werner Kubina; Sebastian Maurer-Stroh; Georg Neuberger; Georg Schneider; Michael Wildpaner
Journal:  Nucleic Acids Res       Date:  2003-07-01       Impact factor: 16.971

9.  Magnitude and breadth of the neutralizing antibody response in the RV144 and Vax003 HIV-1 vaccine efficacy trials.

Authors:  David C Montefiori; Chitraporn Karnasuta; Ying Huang; Hasan Ahmed; Peter Gilbert; Mark S de Souza; Robert McLinden; Sodsai Tovanabutra; Agnes Laurence-Chenine; Eric Sanders-Buell; M Anthony Moody; Mattia Bonsignori; Christina Ochsenbauer; John Kappes; Haili Tang; Kelli Greene; Hongmei Gao; Celia C LaBranche; Charla Andrews; Victoria R Polonis; Supachai Rerks-Ngarm; Punnee Pitisuttithum; Sorachai Nitayaphan; Jaranit Kaewkungwal; Steve G Self; Phillip W Berman; Donald Francis; Faruk Sinangil; Carter Lee; Jim Tartaglia; Merlin L Robb; Barton F Haynes; Nelson L Michael; Jerome H Kim
Journal:  J Infect Dis       Date:  2012-05-25       Impact factor: 5.226

10.  Genetic identity, biological phenotype, and evolutionary pathways of transmitted/founder viruses in acute and early HIV-1 infection.

Authors:  Jesus F Salazar-Gonzalez; Maria G Salazar; Brandon F Keele; Gerald H Learn; Elena E Giorgi; Hui Li; Julie M Decker; Shuyi Wang; Joshua Baalwa; Matthias H Kraus; Nicholas F Parrish; Katharina S Shaw; M Brad Guffey; Katharine J Bar; Katie L Davis; Christina Ochsenbauer-Jambor; John C Kappes; Michael S Saag; Myron S Cohen; Joseph Mulenga; Cynthia A Derdeyn; Susan Allen; Eric Hunter; Martin Markowitz; Peter Hraber; Alan S Perelson; Tanmoy Bhattacharya; Barton F Haynes; Bette T Korber; Beatrice H Hahn; George M Shaw
Journal:  J Exp Med       Date:  2009-06-01       Impact factor: 14.307

View more
  20 in total

1.  CD4- and Time-Dependent Susceptibility of HIV-1-Infected Cells to Antibody-Dependent Cellular Cytotoxicity.

Authors:  Wen Shi Lee; Jérémie Prévost; Jonathan Richard; Reneé M van der Sluis; Sharon R Lewin; Marzena Pazgier; Andrés Finzi; Matthew S Parsons; Stephen J Kent
Journal:  J Virol       Date:  2019-05-01       Impact factor: 5.103

2.  CD4 Incorporation into HIV-1 Viral Particles Exposes Envelope Epitopes Recognized by CD4-Induced Antibodies.

Authors:  Shilei Ding; Romain Gasser; Gabrielle Gendron-Lepage; Halima Medjahed; William D Tolbert; Joseph Sodroski; Marzena Pazgier; Andrés Finzi
Journal:  J Virol       Date:  2019-10-29       Impact factor: 5.103

3.  Mass Cytometric Analysis of HIV Entry, Replication, and Remodeling in Tissue CD4+ T Cells.

Authors:  Marielle Cavrois; Trambak Banerjee; Gourab Mukherjee; Nandhini Raman; Rajaa Hussien; Brandon Aguilar Rodriguez; Joshua Vasquez; Matthew H Spitzer; Nicole H Lazarus; Jennifer J Jones; Christina Ochsenbauer; Joseph M McCune; Eugene C Butcher; Ann M Arvin; Nandini Sen; Warner C Greene; Nadia R Roan
Journal:  Cell Rep       Date:  2017-07-25       Impact factor: 9.423

4.  Detection of the HIV-1 Accessory Proteins Nef and Vpu by Flow Cytometry Represents a New Tool to Study Their Functional Interplay within a Single Infected CD4+ T Cell.

Authors:  Jérémie Prévost; Jonathan Richard; Romain Gasser; Halima Medjahed; Frank Kirchhoff; Beatrice H Hahn; John C Kappes; Christina Ochsenbauer; Ralf Duerr; Andrés Finzi
Journal:  J Virol       Date:  2022-01-26       Impact factor: 6.549

5.  Mucosal stromal fibroblasts markedly enhance HIV infection of CD4+ T cells.

Authors:  Jason A Neidleman; Joseph C Chen; Nargis Kohgadai; Janis A Müller; Anders Laustsen; Karthiga Thavachelvam; Karen S Jang; Christina M Stürzel; Jennifer J Jones; Christina Ochsenbauer; Avantika Chitre; Ma Somsouk; Maurice M Garcia; James F Smith; Ruth M Greenblatt; Jan Münch; Martin R Jakobsen; Linda C Giudice; Warner C Greene; Nadia R Roan
Journal:  PLoS Pathog       Date:  2017-02-16       Impact factor: 6.823

6.  Incomplete Downregulation of CD4 Expression Affects HIV-1 Env Conformation and Antibody-Dependent Cellular Cytotoxicity Responses.

Authors:  Jérémie Prévost; Jonathan Richard; Halima Medjahed; Audrey Alexander; Jennifer Jones; John C Kappes; Christina Ochsenbauer; Andrés Finzi
Journal:  J Virol       Date:  2018-06-13       Impact factor: 5.103

Review 7.  Knowns and Unknowns of Assaying Antibody-Dependent Cell-Mediated Cytotoxicity Against HIV-1.

Authors:  George K Lewis; Margaret E Ackerman; Gabriella Scarlatti; Christiane Moog; Marjorie Robert-Guroff; Stephen J Kent; Julie Overbaugh; R Keith Reeves; Guido Ferrari; Bargavi Thyagarajan
Journal:  Front Immunol       Date:  2019-05-10       Impact factor: 7.561

8.  Development of a Novel In Vitro Primary Human Monocyte-Derived Macrophage Model To Study Reactivation of HIV-1 Transcription.

Authors:  Anna C Hearps; Anthony Jaworowski; Michelle E Wong; Chad J Johnson
Journal:  J Virol       Date:  2021-09-09       Impact factor: 5.103

9.  In vivo imaging of retrovirus infection reveals a role for Siglec-1/CD169 in multiple routes of transmission.

Authors:  Kelsey A Haugh; Mark S Ladinsky; Irfan Ullah; Helen M Stone; Ruoxi Pi; Alexandre Gilardet; Michael W Grunst; Priti Kumar; Pamela J Bjorkman; Walther Mothes; Pradeep D Uchil
Journal:  Elife       Date:  2021-07-05       Impact factor: 8.140

10.  A Protective Role for the Lectin CD169/Siglec-1 against a Pathogenic Murine Retrovirus.

Authors:  Pradeep D Uchil; Ruoxi Pi; Kelsey A Haugh; Mark S Ladinsky; John D Ventura; Brad S Barrett; Mario L Santiago; Pamela J Bjorkman; George Kassiotis; Xaver Sewald; Walther Mothes
Journal:  Cell Host Microbe       Date:  2018-12-27       Impact factor: 21.023

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.